Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy

65Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

We report a durable (12-month) response to capecitabine monotherapy, shown clinically, by MRI, and by cerebrospinal fluid analysis, in a patient with leptomeningeal metastasis from breast cancer.

Cite

CITATION STYLE

APA

Rogers, L. R., Remer, S. E., & Tejwani, S. (2004). Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy. Neuro-Oncology, 6(1), 63–64. https://doi.org/10.1215/S1152851703000334

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free